Levothyroxine compositions having unique triidothyronine plasma AUC properties

Levothyroxine compositions having unique triidothyronine plasma AUC properties

The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Strauss, Elaine, Franz, G, DiMenna, Phillip, Gemma, Rocco
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Strauss, Elaine
Franz, G
DiMenna, Phillip
Gemma, Rocco
description The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.
format Patent
fullrecord <record><control><sourceid>uspatents_EFI</sourceid><recordid>TN_cdi_uspatents_applications_20030198672</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20030198672</sourcerecordid><originalsourceid>FETCH-uspatents_applications_200301986723</originalsourceid><addsrcrecordid>eNrjZPDzSS3LL8moLMqvyMxLVUjOzy3IL84syczPK1bISCzLzEtXKM3LLCxNVSgpysxMgSjNAyktyEkszk1UcAx1Vigoyi9ILSrJTC3mYWBNS8wpTuWF0twMmm6uIc4euqXFBYklqXklxfGJBQU5mcmJYCvijQwMjA0MLS3MzI2MSVELAPRDPvs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Levothyroxine compositions having unique triidothyronine plasma AUC properties</title><source>USPTO Published Applications</source><creator>Strauss, Elaine ; Franz, G ; DiMenna, Phillip ; Gemma, Rocco</creator><creatorcontrib>Strauss, Elaine ; Franz, G ; DiMenna, Phillip ; Gemma, Rocco</creatorcontrib><description>The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.</description><language>eng</language><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20030198672$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,873,885,64059</link.rule.ids><linktorsrc>$$Uhttps://patentcenter.uspto.gov/applications/10219009$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Strauss, Elaine</creatorcontrib><creatorcontrib>Franz, G</creatorcontrib><creatorcontrib>DiMenna, Phillip</creatorcontrib><creatorcontrib>Gemma, Rocco</creatorcontrib><title>Levothyroxine compositions having unique triidothyronine plasma AUC properties</title><description>The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EFI</sourceid><recordid>eNrjZPDzSS3LL8moLMqvyMxLVUjOzy3IL84syczPK1bISCzLzEtXKM3LLCxNVSgpysxMgSjNAyktyEkszk1UcAx1Vigoyi9ILSrJTC3mYWBNS8wpTuWF0twMmm6uIc4euqXFBYklqXklxfGJBQU5mcmJYCvijQwMjA0MLS3MzI2MSVELAPRDPvs</recordid><startdate>20031023</startdate><enddate>20031023</enddate><creator>Strauss, Elaine</creator><creator>Franz, G</creator><creator>DiMenna, Phillip</creator><creator>Gemma, Rocco</creator><scope>EFI</scope></search><sort><creationdate>20031023</creationdate><title>Levothyroxine compositions having unique triidothyronine plasma AUC properties</title><author>Strauss, Elaine ; Franz, G ; DiMenna, Phillip ; Gemma, Rocco</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_applications_200301986723</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Strauss, Elaine</creatorcontrib><creatorcontrib>Franz, G</creatorcontrib><creatorcontrib>DiMenna, Phillip</creatorcontrib><creatorcontrib>Gemma, Rocco</creatorcontrib><collection>USPTO Published Applications</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Strauss, Elaine</au><au>Franz, G</au><au>DiMenna, Phillip</au><au>Gemma, Rocco</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Levothyroxine compositions having unique triidothyronine plasma AUC properties</title><date>2003-10-23</date><risdate>2003</risdate><abstract>The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_applications_20030198672
source USPTO Published Applications
title Levothyroxine compositions having unique triidothyronine plasma AUC properties
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T01%3A39%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFI&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Strauss,%20Elaine&rft.date=2003-10-23&rft_id=info:doi/&rft_dat=%3Cuspatents_EFI%3E20030198672%3C/uspatents_EFI%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true